Study guide
7.4 Pharmaceutical & Chemotherapy/Antineoplastic Waste Segregation (Trace vs Bulk)
AHA/AHE Certified Health Care Environmental Services Professional CHESP
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: CHESP Exam Overview & Study Strategy
1.1 Exam Format, Eligibility & Core Competencies 1.2 Study Planning, Question Analysis & Test-Taking Strategies
2 Chapter 2: Environmental Services Operations & Disinfection Protocols
2.1 Cleaning Chemistry, Surfaces & Soil Removal Principles 2.2 EPA Disinfectants, Chemical Classes & Dwell/Contact Time 2.3 Daily Patient Room & Discharge/Terminal Cleaning Workflows 2.4 Surgical Suites (OR), ICU & High-Risk Clinical Area Protocols 2.5 Enhanced No-Touch Technologies: UV-C, Pulsed Xenon & Electrostatic Sprayers 2.6 Specialty Clinical Areas: L&D, NICU/PICU, Behavioral Health, Interventional Radiology, MRI, Data & Food Areas 2.7 Integrated Pest Management, Odor Control & Oversight of Contracted Services
3 Chapter 3: Infection Prevention & Environmental Microbiology
3.1 The Chain of Infection & Environmental Reservoirs 3.2 High-Consequence Healthcare Pathogens (C. diff, C. auris, MRSA, VRE, CRE, Norovirus) 3.3 Standard vs. Transmission-Based Precautions & Isolation Room Protocols 3.4 Hand Hygiene Standards (WHO 5 Moments) & PPE Donning/Doffing Sequences
4 Chapter 4: Cleaning Quality Assurance & Environmental Surveillance
4.1 ATP Bioluminescence Testing: Science, Benchmarks & Trending 4.2 Fluorescent Marking, Microbiological Culturing & Visual Inspection Audits 4.3 Departmental Quality Audits, Daily Rounding & HCAHPS Cleanliness Drivers
5 Chapter 5: Healthcare Textile & Linen Management
5.1 HLAC Accreditation, Hygienically Clean Standards & OSHA Laundry Rules 5.2 Soil Sorting, Wash Chemistry, Thermal Disinfection & Transport Protocols 5.3 Linen Par Levels, Distribution Systems, Usage Metrics & Loss Prevention
6 Chapter 6: Regulatory Compliance & Life Safety Standards
6.1 The Joint Commission (Environment of Care) & CMS Conditions of Participation 6.2 OSHA Bloodborne Pathogens (1910.1030) & Hazard Communication (1910.1200 / GHS SDS) 6.3 EPA FIFRA Master Labels & DOT Hazardous Materials (49 CFR) Transport 6.4 NFPA 101 Life Safety Code: Egress, Corridor Clutter & 30-Minute Cart Rule 6.5 ASHRAE 170 Ventilation/Air Pressure & Legionella Water Management Plans 6.6 Employment, Accessibility & Privacy Law: ADA, EEOC, FMLA, Workers' Comp & HIPAA 6.7 Emergency Preparedness: 42 CFR §482.15, Hazard Vulnerability Analysis & HICS 6.8 Permits & Licenses, State/Local Agencies, Safety Training Records & HCAHPS/TRISS
7 Chapter 7: Healthcare Waste Stream Management
7.1 Healthcare Waste Classification & Regulatory Framework 7.2 Regulated Medical Waste (RMW), Biohazard Red Bags & Sharps Management 7.3 RCRA Hazardous Waste: P-List, U-List & Characteristic Hazards (D-List) 7.4 Pharmaceutical & Chemotherapy/Antineoplastic Waste Segregation (Trace vs Bulk) 7.5 Universal, Radioactive & Solid Waste: Handler Tiers, Decay-in-Storage & Diversion 7.6 Waste Program Documentation: Characterization Audits, Confidential Destruction & Cradle-to-Grave Manifests
8 Chapter 8: Healthcare Financial Stewardship & Staffing Methodologies
8.1 Healthcare Operating vs. Capital Budgeting Principles 8.2 Full-Time Equivalent (FTE) Calculations: Productive vs. Non-Productive Hours 8.3 AHE Workload Staffing Methodology: Cleanable Sq Ft, Frequency & Time Standards 8.4 Supply Chain Management, PAR Levels, EOQ & Chemical Dispensing Economics 8.5 Contract Management, Outsourcing vs In-House, SLAs & Business Case ROI 8.6 Life-Cycle Costing, Financial Benchmarking & Value Improvement Plans
9 Chapter 9: Departmental Administration, Leadership & Training
9.1 Staff Recruitment, Behavioral Interviewing & Retention Strategies 9.2 Orientation, Competency Verification & AHE CHEST/CSCT Programs 9.3 Continuous Quality Improvement: PDCA/PDSA, Lean, Six Sigma & Root Cause Analysis 9.4 Patient Experience, AIDET Framework, Service Recovery & Workplace Ergonomics 9.5 Strategic Planning: Mission, Vision, SMART Goals, Scope of Services & Policy Development 9.6 Committees, Interdepartmental Coordination, Patient Flow & Equipment Stewardship 9.7 Code of Ethics, Corporate Compliance, Confidentiality & Customer Feedback 9.8 Position Descriptions, Performance Appraisal Instruments, Progressive Discipline & Employer Relations
10 Chapter 10: Planning, Design & Construction (PDC) in Healthcare
10.1 Infection Control Risk Assessment (ICRA) Matrix & Environmental Containment 10.2 Construction Barriers, Negative Air Machines, HEPA Filtration & Post-Construction Clean 10.3 Cleanable Materials & Finishes: Flooring, Walls & Healthcare Furniture Selection 10.4 EVS Architectural Design: Closet Layout, Chemical Dispensing, Sinks & Workflow Routes 10.5 PCRA, the Cleaning Responsibility Matrix & Projecting EVS Cost for New Construction
7.4 Pharmaceutical & Chemotherapy/Antineoplastic Waste Segregation (Trace vs Bulk)
Key Takeaways Explain This Topic AI
EPA 40 CFR Part 266 Subpart P establishes dedicated management standards for hazardous waste pharmaceuticals, strictly banning sewering/flushing down sinks or toilets across all healthcare settings.
Subpart P differentiates between Potentially Creditable pharmaceuticals (undispensed, unexpired/within 1 year, returned to reverse distributors) and Non-Creditable pharmaceuticals (dispensed, partial doses, broken vials, managed on-site for hazardous disposal).
Controlled substances (DEA 21 CFR 1317) are never placed in open blue or black waste containers; they require dual-witness wasting into chemical destruction systems to meet the 'non-retrievable' standard.
Blue containers house non-hazardous, non-controlled pharmaceutical waste destined for high-temperature incineration, while black containers house RCRA hazardous pharmaceuticals and bulk chemotherapy.
Antineoplastic waste is segregated into Yellow Containers for Trace Chemotherapy (<3% residual weight; empty bags, tubing, vials, PPE; incinerated at 1800°F) and Black Containers for Bulk Chemotherapy (>3% residual, un-administered bags, spills; RCRA hazardous waste).
Last updated: August 2026
7.4 Pharmaceutical & Chemotherapy/Antineoplastic Waste Segregation (Trace vs Bulk)
Healthcare environmental services and pharmacy operations intersect critically in the segregation and disposal of pharmaceutical agents and antineoplastic chemotherapy drugs. In 2019, the EPA enacted 40 CFR Part 266 Subpart P (Management Standards for Hazardous Waste Pharmaceuticals) , transforming pharmaceutical waste compliance. Simultaneously, USP <800> (Hazardous Drugs—Handling in Healthcare Settings) and DEA Title 21 CFR Part 1317 enforce strict containment standards protecting healthcare personnel, the environment, and community water systems. EVS leadership must maintain flawless container segregation to prevent illicit diversions, aquatic toxicity, and severe regulatory citations.
1. EPA Subpart P Standards & The Federal Sewer Ban
Codified in 40 CFR Part 266 Subpart P , the EPA established sector-specific regulations tailoring RCRA hazardous waste rules directly to the unique operational realities of healthcare facilities. +-----------------------------------------------------------------------------+
- | EPA 40 CFR PART 266 SUBPART P CORE MANDATES |
- | |
- | 1. THE ABSOLUTE SEWER PROHIBITION (THE SEWER BAN) |
- | - STRICT FEDERAL BAN: No healthcare facility or reverse distributor |
- | may flush, pour, or sewer ANY hazardous waste pharmaceutical down |
- | a sink, toilet, drain, hopper, or sanitary plumbing system. |
- | - Protects municipal wastewater systems, surface waters, and aquifers |
- | from pharmaceutical contamination and endocrine disruption. |
- | |
- | 2. GENERATOR CATEGORY COUNTING EXEMPTION |
- | - Hazardous waste pharmaceuticals managed under Subpart P do NOT count |
- | toward a facility's monthly RCRA generator category totals (VSQG/SQG/LQG).|
- | - Prevents hospitals from oscillating into LQG status due to pharma. |
- | |
- | 3. OTC NICOTINE AMENDMENT |
- | - FDA-approved over-the-counter nicotine replacement therapies (gums, |
- | patches, lozenges) are EXEMPT from P075 acute hazardous waste. |
- | |
- | 4. SEGREGATION OF CREDITABLE VS. NON-CREDITABLE PHARMACEUTICALS |
- | - Establishes separate regulatory pathways for reverse distribution. |
- +-----------------------------------------------------------------------------+
- Potentially Creditable vs. Non-Creditable Pharmaceuticals
Potentially Creditable Hazardous Waste Pharmaceuticals: Un-dispensed, unexpired or less than 1-year expired medications preserved in original manufacturer containers with reasonable expectation of manufacturer credit. These may be shipped to a registered Reverse Distributor without a hazardous waste manifest using standard commercial transit with DOT shipping papers.
Non-Creditable Hazardous Waste Pharmaceuticals: Medications that have been dispensed to a patient, partially administered (partial IV bags, partial ampules), expired past 1 year, broken vials, or patient returns. Non-creditable hazardous pharmaceuticals must never be sent to a reverse distributor . They must be accumulated on-site in Black Hazardous Waste Containers , manifested on EPA Form 8700-22, and transported to a permitted RCRA hazardous TSDF for high-temperature hazardous incineration.
2. Pharmaceutical Segregation Architecture: Blue vs. Black Bins
Healthcare facilities utilize color-coded container systems to segregate non-hazardous pharmaceuticals from RCRA hazardous pharmaceuticals: +-----------------------------------------------------------------------------+
- | PHARMACEUTICAL CONTAINER SEGREGATION MATRIX |
- | |
- | [ BLUE CONTAINER: NON-RCRA PHARMACEUTICAL WASTE ] |
- | - Scope: Non-hazardous, non-controlled discarded pharmaceuticals. |
- | - Key Examples: Antibiotics (penicillin, vancomycin), cardiac meds |
- | (metoprolol, lisinopril), electrolytes, OTC vitamins, analgesics. |
- | - Purpose: Diverts pharmaceuticals from municipal landfills and sewers. |
- | - Final Treatment: Regulated medical waste high-temperature incineration|
- | (destroys active drug molecules). |
- | |
- | [ BLACK CONTAINER: RCRA HAZARDOUS PHARMACEUTICAL WASTE ] |
- | - Scope: P-listed, U-listed, and D-characteristic medications. |
- | - Key Examples: Warfarin >0.3% (P001), Physostigmine (P204), |
- | Arsenic Trioxide (P012), Lindane (U129), Formalin (U122), |
- | Bulk Chemotherapy (>3% residual), Silver Nitrate (D011). |
- | - Final Treatment: Permitted RCRA hazardous waste incineration (TSDF). |
- +-----------------------------------------------------------------------------+
- 3. DEA Controlled Substance Disposal (Title 21 CFR Part 1317)
Controlled substances (Schedules II through V, such as fentanyl, morphine, hydromorphone, oxycodone, lorazepam) are regulated under the Drug Enforcement Administration (DEA) , NOT under EPA RCRA. +-----------------------------------------------------------------------------+
- | DEA CONTROLLED SUBSTANCE WASTING REQUIREMENTS |
- | |
- | 1. THE NON-RETRIEVABLE STANDARD (21 CFR §1317.90) |
- | - Controlled substance waste must be permanently rendered |
- | 'NON-RETRIEVABLE'—chemically destroyed or irreversibly altered so |
- | that the drug cannot be recovered, extracted, or abused. |
- | - Sinks, toilets, and sewer drains do NOT meet the non-retrievable |
- | standard and are strictly prohibited! |
- | |
- | 2. CHEMICAL DESTRUCTION / RENDERING TECHNOLOGY |
- | - Facilities utilize closed chemical sequestration systems |
- | (e.g., Cactus Smart Sink, Rx Destroyer, sequestering canisters). |
- | - Active ingredients are neutralized, solidified, and bound in carbon. |
- | |
- | 3. DUAL-WITNESS DOCUMENTATION MANDATE |
- | - Wasting must be witnessed and digitally documented by TWO licensed |
- | healthcare professionals (e.g., two RNs or RN + Pharmacist) at the |
- | Automated Dispensing Cabinet (Pyxis/Omnicell). |
- | - Controlled substances are NEVER placed in open Blue or Black bins! |
- +-----------------------------------------------------------------------------+
4. Chemotherapy / Antineoplastic Waste: Trace vs. Bulk Protocols
Under USP <800> and EPA guidelines, antineoplastic chemotherapy agents are cytotoxic, mutagenic, and teratogenic. Waste generated during chemo compounding and administration is segregated into Trace Chemotherapy and Bulk Chemotherapy based on the strict RCRA Empty standard (3% residual volume). +-----------------------------------------------------------------------------+
- | CHEMOTHERAPY WASTE SEGREGATION ARCHITECTURE |
- | |
- | TRACE CHEMOTHERAPY (< 3% RESIDUAL) BULK CHEMOTHERAPY (> 3% RESIDUAL) |
- | - RECEPTACLE: Yellow Container / Bags - RECEPTACLE: Black Hazardous Bin |
- | - CRITERIA: Container is 'RCRA Empty' - CRITERIA: Container holds > 3% |
- | with < 3% of drug capacity remaining capacity of active chemo drug. |
- | - INCLUDED ITEMS: - INCLUDED ITEMS: |
- | * Empty IV bags & infusion tubing * Chemo vials with > 3% drug |
- | * Syringes with emptied chemo * Un-administered / canceled IVs|
- | * Chemo gloves, gowns, goggles * Chemo spill cleanup debris |
- | * Alcohol wipes & prep pads * Compounding stock residues |
- | - TREATMENT: High-Temperature - TREATMENT: Permitted RCRA TSDF |
- | Incineration at 1800°F (Yellow Bag). Hazardous Incineration (Black). |
- +-----------------------------------------------------------------------------+
- Pharmaceutical & Chemotherapy Waste Decision Matrix
Waste Item Stream Category Container Color Final Treatment Method
Empty Paclitaxel Chemo IV Bag (<3% residual) Trace Chemotherapy Yellow Rigid Bin / Yellow Bag High-Temperature Medical Incineration (1800°F)
Half-Full Doxorubicin IV Bag (100 mL un-infused) Bulk Chemotherapy (RCRA) Black Hazardous Drum Permitted RCRA Hazardous Incineration (TSDF)
Used Chemo Administration Gloves & Gown Trace Chemotherapy Yellow Biohazard Bin High-Temperature Medical Incineration (1800°F)
Expired Morphine 2 mL Ampule (Controlled) DEA Controlled Substance Chemical Destruction System (Cactus/Rx Destroyer) Non-retrievable chemical rendering & solid waste
Expired Warfarin 5 mg Tablets (U248) RCRA Hazardous Pharma Black Hazardous Container Permitted RCRA Hazardous Incineration (TSDF)
Partial Ceftriaxone IV Bag (Antibiotic) Non-RCRA Pharmaceutical Blue Pharmaceutical Bin High-Temperature Incineration (Non-Hazardous)
Discharged Chemo Spill Kit (>50 mL Spill) Bulk Chemotherapy (RCRA) Black Hazardous Drum Permitted RCRA Hazardous Incineration (TSDF)